Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency

Alexion Pharmaceuticals, Inc. · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
deficiencytype2
cholesterol ester storage disease(cesd), lysosomal acid lipase deficiency, lal-deficiency, enzyme replacement therapy (ert), lysosomal storage disease, late onset lysosomal acid lipase (lal) deficiency, acid cholesteryl ester hydrolase deficiency, type 2, acid lipase disease, cholesterol ester hydrolase deficiency, lal deficiency, lipa deficiency, wolman disease
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 864710
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.